Simultaneous Measurement of Dopamine Transporters and D2/D3 Receptors in Drug Naïve Schizophrenic Patients

키워드

참고문헌 (40)

1. Soares JC, "Neurochemical brain imaging investigations of schizophrenia", Biol Psychiatry, 46, pp.600~615 (1999)
2. Seeman P, "Schizophrenia as a brain disease. The dopamine receptor story", Arch Neurol, 50, pp.1093~1095 (1993)
3. Sedvall G, "Imaging of neurotransmitter receptors in the living human brain", Arch Gen Psychiatry, 43, pp.995~1005 (1986)
4. Farde L, "Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET", Science, 231, pp.258~261 (1986)
5. Wagner HN Jr, "Imaging dopamine receptors in the human brain by positron tomography", Science, 221, pp.1264~1266 (1983)
6. Laruelle M, "Imaging dopamine transmission in schizophrenia. A review and meta-analysis", Q J Nucl Med, 42, pp.211~221 (1998)
7. Suhara T, "Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia", Arch Gen Psychiatry, 59, pp.25~30 (2002)
8. FLB 457, "Int J Neuropsychopharmacol", 2003, 361~370
9. Sotnikova TD, "Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter", CNS Neurol Disord Drug Targets, 5, pp.45~56 (2006)
10. Laakso A, "Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography", Am J Psychiatry, 157, pp.269~271 (2000)
11. Hsiao MC, "Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1", Schizophr Res, 65, pp.39~46 (2003)
12. Laakso A, "Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia", Schizophr Res, 52, pp.115~120 (2001)
13. Mozley LH, "Striatal dopamine transporters and cognitive functioning in healthy men and women", Am J Psychiatry, 158, pp.1492~1499 (2001)
14. Chou YH, "Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: A SPECT study", Eur Neuropsychopharmacol, 17, pp.46~52 (2007)
15. Barnas C, "In vivo (123)I IBZM SPECT imaging of striatal dopamine 2 receptor occupancy in schizophrenic patients", Psychopharmacology (Berl), 157, pp.236~242 (2001)
16. Yang YK, "Associated alterations of striatal dopamine D2", D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study, 2004, pp.161, 1496~1498
17. IBZM in normal and 6-OHDA-lesioned formosan rock monkeys, "Nucl Med Biol", 2002, 561~567
18. Dresel SH, "Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons", J Nucl Med, 40, pp.660~666 (1999)
19. Sheehan DV, "The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10", J Clin Psychiatry, 9(20), pp.22~33 (1998)
20. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition - Text Revision (DSMIV-TR)", American Psychiatric Association, ~ (2000)
21. Kung HF, "Development of Tc-99m labeled tropanes: TRODAT-1, as a dopamine transporter imaging agent", Nucl Med Biol, 28, pp.505~508 (2001)
22. Tzen KY, "Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1", J Nucl Med, 42, pp.408~413 (2001)
23. Kung MP, "The characterization of IBF as a new selective dopamine D-2 receptor imaging agent", J Nucl Med, 31, pp.648~654 (1990)
24. Devous MD Sr, "Dual-isotope brain SPECT imaging with technetium-99m and iodine-123: validation by phantom studies", J Nucl Med, 33, pp.2030~2035 (1992)
25. TRODAT-1 binding to dopamine transporters in nonhuman primates using single-photon emission tomography, "Eur J Nucl Med", 1999, 518~526
26. TRODAT-1: a dopamine transporter imaging agent, "J Nucl Med", 1999, 150~158
27. raclopride binding, "J Cereb Blood Flow Metab", 1998, 941~950
28. raclopride: implications for positron emission tomography of the human brain, "Synapse", 1989, 96~97
29. Laruelle M, "Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects", Proc Natl Acad Sci USA, 93, pp.9235~9240 (1996)
30. Laruelle M, "Increased dopamine transmission in schizophrenia: relationship to illness phases", Biol Psychiatry, 46, pp.56~72 (1999)
31. Seeman P, "Jellinger K, Gabriel E, et al. Bimodal distribution of dopamine receptor densities in brains of schizophrenics", Science, 225, pp.728~731 (1984)
32. Chou YH, "Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study", Synapse, 38, pp.138~143 (2000)
33. Laruelle M, "Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review", J Cereb Blood Flow Metab, 20, pp.423~451 (2000)
34. Hietala J, "Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients", Lancet, 346, pp.1130~1131 (1995)
35. Crow TJ, "Schizophrenia as failure of hemispheric dominance for language", Trends Neurosci, 20, pp.339~343 (1997)
36. DeLisi LE, "Anomalous cerebral asymmetry and language processing in schizophrenia", Schizophr Bull, 23, pp.255~271 (1997)
37. Falkai P, "Loss of sylvian fissure asymmetry in schizophrenia. A quantitative post mortem study", Schizophr Res, 7, pp.23~32 (1992)
38. McGlashan TH, "Schizophrenia as a disorder of developmentally reduced synaptic connectivity", Arch Gen Psychiatry, 57, pp.637~648 (2000)
39. Roberts RC, "The ultrastructural organization of the patch matrix compartments in the human striatum", J Comp Neurol, 452, pp.128~138 (2002)
40. Roberts RC, "Synaptic differences in the patch matrix compartments of subjects with schizophrenia: a postmortem ultrastructural study of the striatum", Neurobiol Dis, 20, pp.324~335 (2005)

관련 논문AI추천